Covid booster vaccines effective against severe illness from omicron, CDC says
I'm a physician over age 50 and I'm not getting my second COVID booster yet. Here's why. | Opinion
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study | The BMJ
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Frequently asked questions and answers about Moderna COVID-19 vaccine | Bangkok Hospital
Boosting immunity to COVID-19 vaccines | Nature Medicine
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Covid booster doses will be offered to over-40s - BBC News
Frontiers | Association Between Risk Perception and Acceptance for a Booster Dose of COVID-19 Vaccine to Children Among Child Caregivers in China
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Moderna says its COVID-19 shot 93% effective six months after second dose | Reuters
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Why do Covid boosters offer greater protection against Omicron?
